Nuveen Asset Management, LLC Oncternal Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.56 $160,547 - $357,792	-229,354 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.37 - $2.43 $4,804 - $8,522	3,507 Added 1.55%	229,354 $346,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $4.39 $46,078 - $89,112	-20,299 Reduced 8.25%	225,847 $551,000
Q3 2021 Nov 12, 2021	BUY	$3.37 - $4.76 $134,287 - $189,676	39,848 Added 19.32%	246,146 $1.04 Million
Q2 2021 Aug 16, 2021	BUY	$4.75 - $9.39 $979,915 - $1.94 Million	206,298 New	206,298 $980,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $62.7M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.